Evidence map›Paper›PMID 35068910›Full record

ArticleCurrent psychology (New Brunswick, N.J.)2022

COVID-19 vaccine literacy in patients with systemic autoimmune diseases.

María Correa-Rodríguez, Blanca Rueda-Medina, José-Luis Callejas-Rubio, Raquel Ríos-Fernández, Javier de la Hera-Fernández, Norberto Ortego-Centeno

Open access · hybridAbstract read
In one paragraph

Article in Current psychology (New Brunswick, N.J.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 2 pooled it
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Vaccine Literacy and Vaccination: A Systematic Review.International journal of public health · 2023
    Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. COVID-19 vaccine literacy: A scoping review.Human vaccines & immunotherapeutics · 2023
    Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. The Development and Preliminary Application of the Chinese Version of the COVID-19 Vaccine Literacy Scale.International journal of environmental research and public health · 2022
    Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

María Correa-RodríguezDepartment of Nursing, Faculty of Health Sciences, University of Granada, Granada, Spain.ORCID 0000-0001-9165-4349
Blanca Rueda-MedinaDepartment of Nursing, Faculty of Health Sciences, University of Granada, Granada, Spain.ORCID 0000-0002-0263-7000
José-Luis Callejas-RubioSystemic Autoimmune Diseases Unit, San Cecilio University Hospital, Granada, Spain.
Raquel Ríos-FernándezSystemic Autoimmune Diseases Unit, San Cecilio University Hospital, Granada, Spain.
Javier de la Hera-FernándezSystemic Autoimmune Diseases Unit, San Cecilio University Hospital, Granada, Spain.
Norberto Ortego-CentenoPresent Address: Instituto de Investigación Biosanitaria Ibs.GRANADA, Granada, Spain.
Instituto de Investigación Biosanitaria de Granada · ESUniversidad de Granada · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

COVID-19 related infodemic is a threat to the successful COVID-19 vaccination campaigns. This might be especially apparent for patients with autoimmune diseases since there is no data available about the balance between benefits and risks of the newly developed COVID-19 vaccines in this population. We aim (i) to evaluate vaccine literacy skills in a population of patients with systemic autoimmune diseases, (ii) to examine the potential associations between vaccine literacy skills and sociodemographic characteristics and (iii) to analyze the relationships between attitudes, perceptions and beliefs about current vaccinations and vaccine literacy skills and sociodemographic characteristics. A cross-sectional study was conducted among 319 patients with systemic autoimmune diseases (92% females; 49.5% of patients in the 31-50 years age category). The vaccine literacy levels were determined using the Health Literacy about Vaccination in adulthood in Italian (HLVa-IT). Sociodemographic characteristics including gender, age, country and area of residence, civil status, socioeconomic status, educational attainment and occupational status were evaluated. The mean vaccine literacy functional and interactive-critical scores were 2.59 ± 0.74 and 3.07 ± 0.60, respectively. The vaccine literacy interactive-critical score was higher in females than in males (p = 0.048). Interactive-critical scores were associated with the area of residence, civil status and socioeconomic status, with the highest score in urban area of ≥ 100.000 inhabitants (p = 0.045), in widow patients (p = 0.023) and in patients with high socioeconomic status (p = 0.018). Significant differences were observed between the different education levels, for both the functional and the interactive-critical scores (p = 0.002 and p < 0.001, respectively), the highest score was observed in patients who completed a university degree. The level of vaccine literacy for functional and interactive-critical scales were medium. Area of residence, civil status and socioeconomic status represented determinants of vaccine literacy interactive-critical scale. Educational attainment also contributes to vaccine literacy functional scale. Insight into these factors is required to ensure an optimal vaccine literacy level in patients with autoimmune diseases. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12144-022-02713-y.

Indexed as

AttitudesBeliefsCovid-19Systemic autoimmune diseasesVaccinationVaccine literacy

Identifiers

PMID35068910
PMCPMC8764502
OpenAlexW4205892329

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.